This announcement is a separate document:
百奧賽圖-B：自願公告就具有同類首創潛力的B7H3/PTK7拓撲異構酶抑制劑有效載荷雙特異性ADC項目與IDEAYA達成選擇權及授權協議
BIOCYTOGEN-B: VOLUNTARY ANNOUNCEMENTENTERS INTO OPTION AND LICENSE AGREEMENT WITH IDEAYAFOR POTENTIAL FIRST-IN-CLASS B7H3/PTK7 TOPO-I-PAYLOADBISPECIFIC ADC PROGRAM
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.